Genetic predisposition to breast cancer: Past, present, and future

被引:196
|
作者
Turnbull, Clare [1 ]
Rahman, Nazneen [1 ]
机构
[1] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England
基金
英国医学研究理事会;
关键词
BRCA*; allele; familial; susceptibility; penetrance;
D O I
10.1146/annurev.genom.9.081307.164339
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In recent years, our understanding of genetic predisposition to breast cancer has advanced significantly. Three classes of predisposition factors, categorized by their associated risks of breast cancer, are currently known. BRCA1 and BRCA2 are high-penetrance breast cancer predisposition genes identified by genome-wide linkage analysis and positional cloning. Mutational screening of genes functionally related to BRCA1 and/or BRCA2 has revealed four genes, CHEK2, ATM, BRIP1, and PALB2; mutations in these genes are rare and confer an intermediate risk of breast cancer. Association studies have further identified eight common variants associated with low-penetrance breast cancer predisposition. Despite these discoveries, most of the familial risk of breast cancer remains unexplained. In this review, we describe the known genetic predisposition factors, expound on the methods by which they were identified, and consider how further technological and intellectual advances may assist in identifying the remaining genetic factors underlying breast cancer susceptibility.
引用
收藏
页码:321 / 345
页数:25
相关论文
共 50 条
  • [21] Genetic predisposition to breast cancer
    Odling-Smee, GW
    BRITISH JOURNAL OF SURGERY, 1998, 85 (02) : 147 - 148
  • [22] Sentinel node biopsy for breast cancer: past, present, and future
    Motomura, Kazuyoshi
    BREAST CANCER, 2015, 22 (03) : 212 - 220
  • [23] EVOLUTION OF BREAST-CANCER SURGERY - PAST, PRESENT, AND FUTURE
    FISHER, B
    GEBHARDT, MC
    SEMINARS IN ONCOLOGY, 1978, 5 (04) : 385 - 394
  • [24] Past, present and future of primary systemic treatment in breast cancer
    José L Alonso-Romero
    Antonio Piero-Madrona
    World Journal of Obstetrics and Gynecology, 2013, (02) : 21 - 33
  • [25] The role of nodal staging in breast cancer Past, present and future
    Hirche, C.
    Mohr, Z.
    Kneif, S.
    Huenerbein, M.
    MINERVA CHIRURGICA, 2010, 65 (05) : 537 - 546
  • [26] SYSTEMIC TREATMENT OF BREAST-CANCER - PAST, PRESENT AND FUTURE
    CARBONE, PP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1976, 1 (7-8): : 759 - 767
  • [27] Treatment of the axilla in early breast cancer: Past, present and future
    Chua, B
    Ung, O
    Boyages, J
    ANZ JOURNAL OF SURGERY, 2001, 71 (12) : 729 - 736
  • [28] The past, present, and future of breast cancer models for nanomedicine development
    Boix-Montesinos, Paz
    Soriano-Teruel, Paula M.
    Arminan, Ana
    Orzaez, Mar
    Vicent, Maria J.
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 173 : 306 - 330
  • [29] Aromatase inhibitors: past, present and future in breast cancer therapy
    Dutta, Udayan
    Pant, Kartikeya
    MEDICAL ONCOLOGY, 2008, 25 (02) : 113 - 124
  • [30] Sentinel node biopsy for breast cancer: past, present, and future
    Kazuyoshi Motomura
    Breast Cancer, 2015, 22 : 212 - 220